Outcome Measures and Metrics in Systemic Lupus Erythematosus
Intro -- Preface -- Acknowledgment -- Contents -- Contributors -- Chapter 1: Introduction: Metrics and Domains Measured in SLE -- Introduction -- Core Set of Domains in SLE, Classification, and Response Criteria -- Core Domain 1: Disease Activity -- Core Domain 2: Chronic Damage Resulting from Lupus Activity or Its Treatment -- Disease Activity and Damage in Special Circumstances: Childhood and Pregnancy -- Childhood -- Pregnancy -- Core Domain 3: Health-Related Quality of Life -- Core Domains 4: Adverse Events of Drugs -- Core Domain 5: Economic Impact -- Emerging Concepts in SLE and Deep Insights on Selected Concepts -- Cognitive Impairment -- Depression and Anxiety -- Fatigue and Pain -- Frailty -- Instrument Selection: The OMERACT Process -- Facilitating Development of Response Criteria and Classification Criteria: EULAR/ACR Collaborative Projects -- Conclusion -- Bibliography -- Chapter 2: Clinical Aspects of Systemic Lupus Erythematosus -- Introduction -- Classification of SLE -- General Manifestations -- Cutaneous Manifestations -- Acute Cutaneous Lupus -- Chronic Cutaneous Lupus -- Non-specific Cutaneous Lesions -- Musculoskeletal Features -- Lupus Myositis -- Other Musculoskeletal Manifestations -- Renal Manifestations -- Neuropsychiatric Manifestations -- Gastrointestinal Involvement -- Mucocutaneous Lesions -- Lupus Enteritis -- Serositis -- Associated Hepatobiliary Manifestations -- Hematologic Manifestations -- Pulmonary Involvement -- Cardiac Manifestations -- Accelerated Atherosclerosis -- References -- Chapter 3: Diagnosis and Classification of Systemic Lupus Erythematosus -- Introduction -- Classification Criteria Are Not Diagnostic Criteria -- 2019 EULAR/ACR Classification Criteria -- Item Generation and New Insights About What Constitutes SLE -- Phase 2. Reducing the Number of Criteria and Other Lessons Learned..
Medienart: |
E-Book |
---|
Erscheinungsjahr: |
2021 ©2021 |
---|---|
Erschienen: |
Cham: Springer International Publishing AG ; 2021 ©2021 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Touma, Zahi [VerfasserIn] |
---|
Links: |
ebookcentral.proquest.com [lizenzpflichtig] |
---|
ISBN: |
---|
Themen: |
---|
Anmerkungen: |
Description based on publisher supplied metadata and other sources |
---|
Umfang: |
1 online resource (422 pages) |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
1816828289 |
---|
LEADER | 01000cam a22002652 4500 | ||
---|---|---|---|
001 | 1816828289 | ||
003 | DE-627 | ||
005 | 20230427035118.0 | ||
007 | cr uuu---uuuuu | ||
008 | 220916s2021 xx |||||o 00| ||eng c | ||
020 | |a 9783030733032 |9 978-3-030-73303-2 | ||
035 | |a (DE-627)1816828289 | ||
035 | |a (DE-599)KEP067361412 | ||
035 | |a (EBC)EBC6682836 | ||
035 | |a (EBL)EBL6682836 | ||
035 | |a (EBP)067361412 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
082 | 0 | |a 616.772 | |
100 | 1 | |a Touma, Zahi |e verfasserin |4 aut | |
245 | 1 | 0 | |a Outcome Measures and Metrics in Systemic Lupus Erythematosus |
264 | 1 | |a Cham |b Springer International Publishing AG |c 2021 | |
264 | 4 | |c ©2021 | |
300 | |a 1 online resource (422 pages) | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Description based on publisher supplied metadata and other sources | ||
520 | |a Intro -- Preface -- Acknowledgment -- Contents -- Contributors -- Chapter 1: Introduction: Metrics and Domains Measured in SLE -- Introduction -- Core Set of Domains in SLE, Classification, and Response Criteria -- Core Domain 1: Disease Activity -- Core Domain 2: Chronic Damage Resulting from Lupus Activity or Its Treatment -- Disease Activity and Damage in Special Circumstances: Childhood and Pregnancy -- Childhood -- Pregnancy -- Core Domain 3: Health-Related Quality of Life -- Core Domains 4: Adverse Events of Drugs -- Core Domain 5: Economic Impact -- Emerging Concepts in SLE and Deep Insights on Selected Concepts -- Cognitive Impairment -- Depression and Anxiety -- Fatigue and Pain -- Frailty -- Instrument Selection: The OMERACT Process -- Facilitating Development of Response Criteria and Classification Criteria: EULAR/ACR Collaborative Projects -- Conclusion -- Bibliography -- Chapter 2: Clinical Aspects of Systemic Lupus Erythematosus -- Introduction -- Classification of SLE -- General Manifestations -- Cutaneous Manifestations -- Acute Cutaneous Lupus -- Chronic Cutaneous Lupus -- Non-specific Cutaneous Lesions -- Musculoskeletal Features -- Lupus Myositis -- Other Musculoskeletal Manifestations -- Renal Manifestations -- Neuropsychiatric Manifestations -- Gastrointestinal Involvement -- Mucocutaneous Lesions -- Lupus Enteritis -- Serositis -- Associated Hepatobiliary Manifestations -- Hematologic Manifestations -- Pulmonary Involvement -- Cardiac Manifestations -- Accelerated Atherosclerosis -- References -- Chapter 3: Diagnosis and Classification of Systemic Lupus Erythematosus -- Introduction -- Classification Criteria Are Not Diagnostic Criteria -- 2019 EULAR/ACR Classification Criteria -- Item Generation and New Insights About What Constitutes SLE -- Phase 2. Reducing the Number of Criteria and Other Lessons Learned. | ||
650 | 0 | |a Systemic lupus erythematosus-Diagnosis | |
650 | 4 | |a Electronic books | |
776 | 1 | |z 9783030733025 | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783030733025 |
856 | 4 | 0 | |u https://ebookcentral.proquest.com/lib/kxp/detail.action?docID=6682836 |m X:EBC |x Aggregator |z lizenzpflichtig |
912 | |a ZDB-30-PQE | ||
912 | |a GBV_ILN_24 | ||
912 | |a ISIL_DE-8 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_206 | ||
912 | |a ISIL_DE-Brg3 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a ISIL_DE-291 | ||
912 | |a GBV_ILN_2021 | ||
912 | |a ISIL_DE-289 | ||
951 | |a BO | ||
953 | |2 045F |a 616.772 | ||
980 | |2 24 |1 01 |x 0008 |b 4189499048 |h olr-ddaebc |k Diesen Titel können Sie über den Zugriffslink zunächst für kurze Zeit nutzen (1 Campuszugriff zur Zeit möglich) und bei weiterem Bedarf nach persönlicher Registrierung auf der nachfolgenden Seite der Zentralbibliothek zur dauerhaften Anschaffung vorschlagen. Wir werden Sie zügig über die Bereitstellung informieren. |y z |z 16-09-22 | ||
980 | |2 206 |1 01 |x 3350 |b 4189637181 |c 00 |f --%%-- |d Online-Ressource |e g |j --%%-- |h OLR-EBL |k If you are a ThHF affiliate and the E-Book is not fully accessible, please send us a purchase or short time loan request. All others: Inter-library loans and guest access on campus premises is not possible. |y zh |z 17-09-22 | ||
980 | |2 2005 |1 01 |x DE-291 |b 4285864517 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Zugriff nur aus dem Universitätsnetz. |y l01 |z 09-03-23 | ||
980 | |2 2021 |1 01 |x DE-289 |b 419293454X |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |y l01 |z 28-09-22 | ||
981 | |2 24 |1 01 |x 0008 |r https://ebookcentral.proquest.com/lib/christianalbrechts/detail.action?docID=6682836 | ||
981 | |2 206 |1 01 |x 3350 |y Full Text only for ThHf affiliates |r https://thh-friedensau.idm.oclc.org/login?url=http://ebookcentral.proquest.com/lib/thhfriedensau/detail.action?docID=6682836 | ||
981 | |2 2005 |1 01 |x DE-291 |r https://ebookcentral.proquest.com/lib/sulb/detail.action?docID=6682836 | ||
981 | |2 2021 |1 01 |x DE-289 |r https://ebookcentral.proquest.com/lib/kiz-uniulm/detail.action?docID=6682836 | ||
995 | |2 24 |1 01 |x 0008 |a olr-ddaebc | ||
995 | |2 206 |1 01 |x 3350 |a OLR-EBL |